Other
Steroid
0
Pipeline Programs↗
16
Active Trials↗
5
Companies Involved↗
Steroid is an early-stage landscape with 0 programs across 5 companies. The most active players are Novartis, Pfizer, AstraZeneca.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
85
clinical trials
Completed42 · 49%
Unknown status14 · 16%
Recruiting10 · 12%
Terminated8 · 9%
Withdrawn5 · 6%
Not yet recruiting3 · 4%
Other3 · 4%
Clinical Trials
Trial Activity
85 trials
Once Weekly Infant Corticosteroid Trial for DMD
Recruiting·—·Phase 4·NCT05412394·26 enrolled
A Study to Compare Different Ways of Steroid Administration After Total Knee Implantation
Recruiting·—·Phase 4·NCT04432012·159 enrolled
Anti-protozoal Effect of Steroid Hormone 20-hydroxyecdysone
Active, not recruiting·RResearch Institute of Epidemiology, Microbiology and Infectious Diseases, Uzbekistan·Phase 2/3·NCT04827537·200 enrolled
How Long Should we Give Steroids for Patients With Severe PCP
Not yet recruiting·MMcGill University Health Centre/Research Institute of the McGill University Health Centre·Phase 4·NCT07328984·416 enrolled
Inectolizumab With Steroid Optimization in Newly Treated NMOSD
Not yet recruiting·FFirst Affiliated Hospital of Wenzhou Medical University·N/A·NCT07159893·25 enrolled
Page 1 of 6
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)